Close



Mar 1, 2024 08:31AM
Mar 1, 2024 08:30AM
Nov 9, 2023 04:05PM
Sep 18, 2023 04:11PM
Sep 18, 2023 04:10PM
Aug 8, 2023 04:05PM
Apr 17, 2023 02:39PM Kinnate Biopharma (KNTE) Adds Two New Drug Candidates to Its Growing Targeted Oncology Pipeline and Provides Cash Runway Guidance
Apr 17, 2023 02:35PM
Mar 15, 2023 04:05PM
Feb 14, 2023 04:36PM
Feb 14, 2023 04:05PM
Jan 26, 2023 04:05PM
Nov 10, 2022 04:05PM
Sep 21, 2022 04:05PM Kinnate Biopharma (KNTE) Granted FDA Fast Track Designation for KIN-2787
Sep 21, 2022 04:05PM
Sep 15, 2022 04:05PM
Aug 11, 2022 04:05PM
Apr 8, 2022 04:32PM
Apr 8, 2022 04:30PM
Mar 28, 2022 04:05PM
Jan 19, 2022 04:05PM Kinnate Biopharma Inc. to Present Preclinical Data on its FGFR Inhibitor Candidate at the ASCO Gastrointestinal Cancers Symposium
Jan 18, 2022 04:06PM
Jan 18, 2022 04:05PM
Jan 6, 2022 04:05PM
Nov 10, 2021 04:05PM
Oct 7, 2021 09:00AM
Sep 13, 2021 08:00AM
Jun 4, 2021 08:04AM Kinnate Biopharma (KNTE) Presents Preclinical Data From its Lead RAF Inhibitor Candidate KIN-2787 at ASCO 2021
Jun 4, 2021 08:00AM
May 17, 2021 04:05PM
Mar 29, 2021 04:05PM

251,817 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All